secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001193125-26-126220
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences reports FY2025 net loss of $2.3M; Zola revenues up 17% YoY; business combination terminated
--------------------------------------------------------------------------------

- Q4 2025 revenue $901K (-26% YoY); full-year revenue $4.86M (-4%). Net loss per share $1.71 vs $5.17 in 2024.
- Zola coconut water sales rose 17% to $701K in 2025; SG&A reduced 27% YoY.
- Roosevelt Resources terminated proposed business combination; Arcadia exercises preferred options for $2.1M gross proceeds.
- Cash and short-term investments totaled $4.56M at Dec 31, 2025, down from $4.24M cash alone a year earlier.
- Net cash used in operations improved 49% to $4.74M in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526126220/0001193125-26-126220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526126220/rkda-20260326.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-126220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer